Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › BOSTON › BETH ISRAEL DEACONESS MEDICAL CENTER, INC.

BETH ISRAEL DEACONESS MEDICAL CENTER, INC.

NPI: 1548202641 · BOSTON, MA 02215 · General Acute Care Hospital · NPI assigned 06/12/2006

$270.28M
Total Medicaid Paid
7,802,371
Total Claims
6,838,073
Beneficiaries
847
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBHOGADI, SATISH (CHIEF FINANCIAL OFFICER)
NPI Enumeration Date06/12/2006

Related Entities

Other providers sharing the same authorized official: BHOGADI, SATISH

ProviderCityStateTotal Paid
BETH ISRAEL DEACONESS MEDICAL CENTER, INC CHESTNUT HILL MA $506.94

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,114,724 $34.06M
2019 1,147,076 $34.45M
2020 931,455 $27.77M
2021 1,277,877 $43.03M
2022 1,251,398 $50.48M
2023 1,172,075 $45.94M
2024 907,766 $34.55M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 183,753 160,009 $25.76M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 118,831 104,654 $15.77M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 97,649 83,567 $14.10M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 30,288 19,886 $9.09M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 312,416 239,964 $8.32M
96361 Intravenous infusion, hydration; each additional hour 21,591 17,851 $7.80M
J9271 Injection, pembrolizumab, 1 mg 968 808 $7.55M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 36,504 32,930 $6.82M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 8,878 8,750 $5.13M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 42,899 39,488 $5.06M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,108 2,735 $4.93M
45380 Colonoscopy, flexible; with biopsy, single or multiple 7,290 7,165 $4.66M
96415 8,700 6,942 $4.58M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 5,941 5,831 $4.57M
99284 Emergency department visit for the evaluation and management, high severity 29,213 26,974 $4.36M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 27,606 21,606 $3.78M
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 4,507 4,408 $3.37M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 9,558 7,086 $3.25M
J3380 Injection, vedolizumab, intravenous, 1 mg 638 585 $3.02M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 56,148 24,347 $2.94M
78815 Positron emission tomography (PET) for limited area imaging 3,425 3,281 $2.72M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 47,539 43,001 $2.59M
99215 Prolong outpt/office vis 16,470 14,582 $2.50M
99283 Emergency department visit for the evaluation and management, moderate severity 15,396 14,240 $2.15M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 7,665 7,469 $2.01M
G0378 Hospital observation service, per hour 17,341 14,644 $1.98M
74177 Computed tomography, abdomen and pelvis; with contrast material 15,471 14,810 $1.90M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 11,956 11,715 $1.80M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 63,757 62,180 $1.70M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 63,783 62,194 $1.68M
74183 6,658 6,509 $1.65M
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 1,288 934 $1.57M
20610 10,910 10,037 $1.54M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 12,177 10,975 $1.45M
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 1,856 769 $1.44M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 10,530 10,158 $1.41M
J2357 Injection, omalizumab, 5 mg 1,535 943 $1.40M
59025 Fetal non-stress test 5,392 4,343 $1.37M
J0585 Injection, onabotulinumtoxina, 1 unit 3,976 2,830 $1.35M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 23,459 22,683 $1.31M
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 10,002 9,815 $1.23M
84443 Thyroid stimulating hormone (TSH) 122,718 119,205 $1.23M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 29,644 26,743 $1.23M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 8,439 8,177 $1.20M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 56,595 55,954 $1.18M
J2323 Injection, natalizumab, 1 mg 1,031 974 $1.16M
76705 Ultrasound, abdominal, real time with image documentation; limited 11,274 10,965 $1.13M
90834 Psychotherapy, 45 minutes with patient 21,491 13,254 $1.12M
31579 2,272 2,184 $1.11M
J2505 Injection, pegfilgrastim, 6 mg 653 484 $1.10M
70450 Computed tomography, head or brain; without contrast material 9,929 9,260 $1.09M
96367 7,854 6,350 $1.08M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 9,522 7,537 $1.08M
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 2,232 2,126 $1.04M
96375 Therapeutic injection; each additional sequential IV push 27,835 21,050 $1.04M
76819 Fetal biophysical profile; without non-stress testing 11,341 7,080 $1.03M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 27,959 23,205 $1.02M
76700 Ultrasound, abdominal, real time with image documentation; complete 7,341 7,259 $1.02M
83036 Hemoglobin; glycosylated (A1C) 149,192 146,959 $995K
96110 Developmental screening, with scoring and documentation, per standardized instrument 6,222 6,197 $978K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 49,125 44,180 $893K
72197 3,812 3,731 $878K
77063 Screening digital breast tomosynthesis, bilateral 15,031 14,918 $866K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 12,296 12,076 $861K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 2,842 1,921 $852K
76830 Ultrasound, transvaginal 9,555 9,359 $845K
62323 2,101 2,072 $826K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 188,582 160,950 $811K
43235 1,349 1,308 $796K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 9,633 9,470 $789K
85027 186,417 164,730 $756K
80051 182,251 162,589 $733K
93971 5,560 5,258 $731K
31575 4,005 3,829 $724K
76642 8,491 7,132 $697K
77067 Screening mammography, bilateral, including computer-aided detection 18,687 18,541 $689K
52000 1,379 1,348 $684K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 4,667 4,641 $681K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 20,809 17,248 $653K
J1453 Injection, fosaprepitant, 1 mg 3,981 2,623 $648K
80061 Lipid panel 144,780 142,587 $641K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 26,198 25,973 $619K
71275 Computed tomographic angiography, chest, with contrast material 3,665 3,555 $610K
88305 Level IV - Surgical pathology, gross and microscopic examination 37,832 36,431 $605K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 34,149 33,619 $597K
71260 Computed tomography, thorax, diagnostic; with contrast material 9,031 8,796 $588K
76813 4,263 4,235 $588K
J9299 Injection, nivolumab, 1 mg 211 155 $587K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1,696 1,658 $563K
76536 5,830 5,760 $556K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 5,374 5,214 $555K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 3,788 3,708 $555K
76801 4,356 3,976 $540K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 16,112 14,913 $530K
31231 3,262 3,147 $525K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 3,112 3,058 $525K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 17,188 8,412 $524K
71046 Radiologic examination, chest; 2 views 33,627 31,619 $521K
97161 8,329 8,092 $494K
96416 2,048 1,234 $492K
99219 2,284 2,211 $491K
64615 1,918 1,867 $481K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 2,565 2,447 $479K
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 448 310 $476K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 17,772 17,376 $463K
J2350 Injection, ocrelizumab, 1 mg 44 40 $449K
J9312 Injection, rituximab, 10 mg 197 111 $436K
91200 5,454 5,312 $432K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 7,615 7,173 $403K
71250 7,054 6,868 $401K
83735 109,199 77,524 $397K
70496 1,998 1,937 $387K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 1,880 1,761 $387K
70551 Magnetic resonance imaging, brain; without contrast material 2,299 2,242 $385K
87517 13,329 12,885 $383K
36430 1,458 879 $378K
S9485 Crisis intervention mental health services, per diem 814 719 $371K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 19,495 18,084 $369K
76775 4,113 4,032 $366K
87086 Culture, bacterial; quantitative colony count, urine 68,486 62,458 $366K
20611 1,342 1,297 $366K
58300 1,319 1,291 $357K
86481 5,812 5,632 $352K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg 479 478 $351K
97162 6,574 6,369 $349K
74176 Computed tomography, abdomen and pelvis; without contrast material 2,764 2,663 $338K
90853 Group psychotherapy (other than of a multiple-family group) 5,697 2,027 $335K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 2,895 2,277 $335K
97803 4,549 4,305 $317K
82565 286,189 255,783 $317K
94010 8,142 7,896 $304K
86803 30,314 29,753 $304K
93970 1,582 1,530 $303K
67028 Intravitreal injection of a pharmacologic agent 2,451 2,272 $298K
84439 50,050 48,286 $295K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 3,538 3,033 $288K
86780 27,042 26,616 $286K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 535 511 $285K
82728 36,298 34,843 $284K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 20,171 17,751 $282K
90686 15,535 15,357 $277K
20550 1,795 1,620 $272K
93017 3,559 3,472 $270K
84460 260,633 229,502 $259K
72141 1,651 1,618 $258K
82105 23,001 22,234 $258K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 67,790 61,526 $256K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,578 2,389 $254K
86480 6,095 5,971 $251K
88307 3,606 3,471 $248K
84450 246,729 216,005 $236K
87340 31,590 30,817 $233K
93320 2,283 2,236 $229K
82607 29,257 28,674 $229K
77336 3,273 1,668 $228K
87536 5,578 5,444 $223K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 3,398 3,355 $222K
92551 2,002 1,992 $217K
90715 8,676 8,522 $211K
80048 Basic metabolic panel (calcium, ionized) 46,008 38,153 $208K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 30,287 29,616 $208K
95886 1,117 1,059 $205K
83970 12,397 11,843 $200K
J1610 Injection, glucagon hydrochloride, per 1 mg 1,719 1,670 $199K
86850 29,678 25,987 $196K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,529 2,527 $195K
97802 2,873 2,817 $195K
84153 17,709 17,290 $193K
77066 Tomosynthesis, mammo 5,708 5,604 $192K
77334 1,038 766 $185K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1,406 953 $185K
96402 3,623 3,386 $182K
95117 5,206 2,736 $179K
83880 11,373 10,339 $179K
81001 88,626 82,245 $177K
90832 Psychotherapy, 30 minutes with patient 3,623 2,876 $177K
0002A 7,093 6,592 $177K
74178 1,686 1,660 $174K
84520 257,697 229,930 $173K
86706 22,600 21,965 $172K
88342 7,847 7,579 $170K
93296 6,539 6,427 $170K
J1050 Injection, medroxyprogesterone acetate, 1 mg 2,672 2,640 $169K
84484 21,492 18,138 $168K
84466 24,683 23,875 $165K
77065 Tomosynthesis, mammo 3,846 3,653 $161K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,231 1,995 $161K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg 125 116 $161K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 17,825 9,166 $160K
20553 1,306 1,228 $159K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1,003 982 $156K
84702 12,261 9,864 $150K
85610 63,910 50,283 $150K
Q3014 Telehealth originating site facility fee 43,190 37,495 $150K
J3010 Injection, fentanyl citrate, 0.1 mg 29,628 28,126 $150K
17110 1,077 1,023 $148K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 15,827 15,703 $145K
58301 586 579 $141K
93325 2,755 2,685 $141K
82247 140,599 113,479 $141K
36415 Collection of venous blood by venipuncture 109,009 91,646 $138K
97530 Therapeutic activities, direct patient contact, each 15 minutes 3,867 3,042 $135K
J1644 Injection, heparin sodium, per 1000 units 20,140 10,463 $135K
0001A 6,904 6,525 $134K
86900 30,797 26,785 $130K
76937 1,278 1,157 $130K
87522 Neg quan hep c or qual rna 4,612 4,462 $128K
J2250 Injection, midazolam hydrochloride, per 1 mg 31,934 30,497 $127K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1,968 1,967 $126K
90791 Psychiatric diagnostic evaluation 1,512 1,460 $123K
83655 10,488 10,410 $123K
88341 4,548 4,323 $122K
87102 18,902 18,243 $120K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 1,545 1,433 $120K
83690 27,396 24,487 $119K
82043 40,448 39,681 $119K
77062 1,870 1,845 $119K
90750 2,125 2,082 $118K
82947 94,307 86,596 $118K
86762 10,148 9,950 $115K
67228 381 297 $114K
81025 20,909 17,673 $114K
82784 12,454 11,193 $113K
11102 376 369 $111K
76942 2,225 2,159 $111K
86704 13,879 13,549 $108K
J7050 Infusion, normal saline solution, 250 cc 40,210 24,626 $105K
84075 143,462 117,498 $103K
80069 31,044 24,212 $102K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,494 1,488 $101K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4,716 4,138 $99K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,126 2,036 $97K
83540 27,961 27,030 $97K
83605 12,969 11,399 $97K
86140 30,705 28,681 $97K
J1437 Injection, ferric derisomaltose, 10 mg 210 205 $96K
J2405 Injection, ondansetron hydrochloride, per 1 mg 35,052 26,966 $95K
85730 24,920 20,528 $94K
86787 9,889 9,689 $93K
80053 Comprehensive metabolic panel 18,035 14,210 $93K
86360 4,879 4,742 $91K
82040 72,089 63,010 $89K
73562 8,525 8,069 $88K
82746 10,609 10,360 $86K
J7030 Infusion, normal saline solution , 1000 cc 9,599 5,288 $86K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,324 1,310 $86K
86901 30,591 26,603 $85K
72100 4,100 3,989 $84K
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 35 24 $84K
84403 5,960 5,716 $84K
88112 3,119 3,003 $83K
74174 682 666 $82K
87205 24,304 23,207 $82K
94729 3,394 3,296 $81K
90836 992 343 $81K
77386 370 38 $80K
92134 9,435 8,694 $79K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 4,337 4,257 $79K
76882 859 791 $79K
86003 1,097 1,056 $78K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 287 221 $77K
87081 12,701 12,560 $77K
11900 393 385 $77K
J1885 Injection, ketorolac tromethamine, per 15 mg 18,366 15,204 $76K
99173 1,496 1,491 $76K
19083 61 61 $75K
77300 431 386 $74K
82378 8,011 6,381 $73K
82570 26,718 25,839 $72K
ATP07 12,069 9,955 $71K
73030 7,538 7,196 $71K
73630 7,243 6,795 $70K
ATP14 10,428 7,474 $69K
64405 249 244 $69K
83520 6,980 6,572 $69K
96401 1,942 1,177 $69K
J2704 Injection, propofol, 10 mg 32,664 30,922 $67K
71045 Radiologic examination, chest; single view 9,300 8,077 $65K
84100 75,770 55,746 $63K
84146 4,635 4,471 $63K
80197 11,604 6,862 $61K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 217 217 $61K
87040 5,628 4,817 $61K
58100 216 212 $60K
87186 11,755 11,197 $60K
83001 4,505 4,424 $60K
73130 5,961 5,651 $59K
11100 404 386 $57K
93351 1,184 1,168 $57K
17311 167 149 $56K
ATP09 9,705 7,263 $55K
51741 1,317 1,258 $55K
87799 3,304 2,201 $55K
99201 475 445 $55K
0012A 1,801 1,550 $55K
99385 584 579 $54K
90677 1,500 1,470 $54K
0011A 1,776 1,530 $54K
92083 4,135 3,966 $54K
70491 558 546 $54K
72158 362 356 $54K
86160 3,969 3,801 $53K
82310 62,968 51,931 $53K
87338 4,805 4,771 $53K
86038 6,625 6,495 $52K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 982 954 $52K
J1170 Injection, hydromorphone, up to 4 mg 14,875 10,529 $52K
86708 6,409 6,260 $51K
84480 5,788 5,545 $51K
77049 130 130 $51K
90837 Psychotherapy, 53 minutes with patient 798 515 $50K
71271 1,107 1,094 $50K
J3490 Unclassified drugs 2,489 2,178 $50K
73610 5,925 5,326 $50K
G0297 Low dose ct scan (ldct) for lung cancer screening 629 613 $49K
87077 9,633 9,176 $48K
73221 248 235 $47K
86235 1,343 1,246 $47K
36591 8,223 5,510 $47K
J9310 Injection, rituximab, 100 mg 39 25 $47K
73502 4,865 4,668 $47K
86765 5,292 5,142 $47K
J0897 Injection, denosumab, 1 mg 211 209 $46K
ATP12 8,018 6,496 $46K
99220 102 101 $46K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 17,512 14,154 $46K
73560 3,027 2,823 $45K
88148 5,488 5,402 $45K
76820 761 346 $45K
82670 2,254 2,200 $45K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,813 3,723 $44K
99218 326 316 $44K
81003 30,801 29,000 $42K
64450 152 146 $42K
77290 218 202 $42K
86735 4,762 4,620 $41K
J3111 Injection, romosozumab-aqqg, 1 mg 37 36 $40K
92133 5,207 5,025 $40K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 33 33 $39K
84156 18,950 15,939 $39K
72125 Computed tomography, cervical spine; without contrast material 3,871 3,651 $38K
93923 764 742 $38K
84165 8,244 7,646 $37K
84132 38,557 34,427 $36K
88185 340 311 $35K
J0690 Injection, cefazolin sodium, 500 mg 13,333 10,834 $35K
93975 336 322 $34K
82803 2,155 1,855 $34K
G0008 Administration of influenza virus vaccine 9,382 9,275 $34K
77002 600 561 $33K
ATP13 6,945 5,218 $33K
88173 1,088 1,058 $33K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,897 4,524 $33K
86304 2,902 2,331 $33K
72156 91 90 $32K
99442 1,775 1,545 $32K
88304 3,884 3,803 $32K
73110 3,630 3,286 $32K
ATP06 8,789 7,565 $32K
58558 14 14 $32K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 3,537 3,464 $31K
86832 459 458 $31K
96417 5,643 3,767 $31K
86255 3,308 3,198 $31K
J0485 Injection, belatacept, 1 mg 132 78 $31K
77412 202 24 $30K
80050 General health panel 1,871 1,748 $30K
86923 1,232 1,046 $29K
99397 1,371 1,324 $29K
99282 Emergency department visit for the evaluation and management, low to moderate severity 217 211 $29K
90732 1,574 1,544 $29K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 33,863 31,620 $29K
ATP11 5,811 4,932 $28K
70498 1,227 1,193 $28K
72040 1,676 1,597 $28K
83516 1,721 1,695 $28K
J7070 Infusion, d5w, 1000 cc 14,952 7,260 $28K
J1630 Injection, haloperidol, up to 5 mg 3,363 2,911 $28K
87497 1,428 769 $27K
69210 689 632 $27K
99406 1,769 1,694 $27K
86831 1,194 1,170 $27K
83002 1,926 1,886 $27K
85379 3,750 3,616 $27K
J1650 Injection, enoxaparin sodium, 10 mg 2,181 1,009 $26K
ATP04 7,503 6,547 $26K
87088 5,239 5,044 $26K
87070 4,917 4,608 $26K
64400 56 56 $26K
96368 1,496 1,053 $25K
ATP03 13,435 11,660 $25K
86830 1,103 1,082 $25K
J0178 Injection, aflibercept, 1 mg 37 36 $25K
83718 4,576 4,538 $25K
86359 1,389 1,360 $24K
97165 263 258 $24K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 599 591 $24K
88312 1,411 1,371 $24K
ATP15 3,760 2,668 $24K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 92 86 $24K
84270 1,385 1,345 $24K
81002 10,247 7,994 $24K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 3,149 2,913 $24K
ATP08 5,751 5,144 $23K
86592 6,651 6,523 $23K
99205 Prolong outpt/office vis 152 150 $23K
86833 426 422 $23K
97166 356 346 $23K
A9585 Injection, gadobutrol, 0.1 ml 22,264 21,413 $23K
86301 2,615 2,082 $23K
96040 2,378 2,232 $22K
ATP10 4,667 4,063 $22K
17000 628 603 $22K
87046 2,411 2,329 $22K
ATP05 4,476 4,077 $22K
83615 26,900 18,351 $22K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 78 73 $22K
82550 17,716 16,596 $22K
82533 1,889 1,627 $22K
80299 2,793 2,268 $22K
82397 2,923 2,865 $22K
J2060 Injection, lorazepam, 2 mg 4,496 3,635 $21K
36561 26 25 $21K
90662 3,634 3,564 $21K
C9257 Injection, bevacizumab, 0.25 mg 1,299 699 $20K
86618 1,245 1,219 $20K
90746 774 758 $20K
99153 Mod sedat endo service >5yrs 7,386 7,048 $20K
G0127 Trimming of dystrophic nails, any number 3,386 3,247 $20K
90670 676 664 $19K
86769 960 918 $19K
83020 1,375 1,364 $19K
64493 27 26 $19K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies 27 27 $19K
90870 98 38 $19K
77061 263 259 $18K
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring 295 289 $18K
91300 5,969 4,732 $18K
99152 7,932 7,543 $18K
83010 2,814 2,499 $18K
85007 8,846 5,797 $18K
86800 1,633 1,591 $18K
C1769 Guide wire 5,252 4,870 $18K
83521 2,238 1,863 $17K
J1200 Injection, diphenhydramine hcl, up to 50 mg 8,035 5,989 $17K
84550 24,601 19,423 $17K
76770 135 134 $17K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 14 13 $17K
87045 2,363 2,293 $17K
11104 28 28 $17K
20552 98 92 $17K
91322 279 276 $17K
84295 25,593 22,400 $17K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 10,469 10,109 $17K
J3489 Injection, zoledronic acid, 1 mg 1,461 1,395 $16K
J3475 Injection, magnesium sulfate, per 500 mg 7,100 4,069 $16K
85045 7,121 6,514 $16K
J2270 Injection, morphine sulfate, up to 10 mg 7,697 6,147 $16K
90739 216 205 $15K
74230 187 182 $15K
96376 6,062 5,359 $15K
82150 3,832 3,284 $15K
93926 48 48 $15K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 3,044 2,920 $15K
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg 58 36 $15K
80076 5,182 4,440 $14K
99443 385 329 $14K
0003A 736 719 $14K
51798 2,970 2,915 $14K
84166 1,905 1,827 $14K
76377 5,007 4,866 $14K
96523 652 595 $14K
96411 2,065 1,380 $14K
82248 15,807 13,290 $14K
86225 1,612 1,564 $13K
77295 32 26 $13K
ATP02 4,308 3,811 $13K
90472 Immunization administration, each additional vaccine (list separately) 6,859 6,761 $13K
J1815 Injection, insulin, per 5 units 2,407 1,139 $12K
86430 3,120 3,087 $12K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 1,871 1,643 $12K
82465 5,948 5,876 $12K
76870 130 128 $12K
ATP16 1,864 1,354 $12K
83721 2,670 2,630 $11K
49083 52 25 $11K
J1030 Injection, methylprednisolone acetate, 40 mg 5,769 5,561 $11K
87209 930 840 $11K
90734 162 162 $11K
82553 1,959 1,670 $11K
88313 648 628 $11K
86200 1,320 1,305 $11K
88184 357 325 $11K
93308 64 63 $11K
94060 85 83 $11K
84432 844 816 $11K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 1,663 1,614 $10K
J3370 Injection, vancomycin hcl, 500 mg 2,217 1,473 $10K
51784 85 79 $10K
J9263 Injection, oxaliplatin, 0.5 mg 303 133 $10K
74181 14 14 $10K
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg 13 13 $10K
87147 2,274 2,243 $10K
84425 584 581 $10K
ATP17 1,763 1,497 $10K
92226 1,301 1,236 $9K
73590 1,323 1,214 $9K
0124A 452 445 $9K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 160 145 $9K
76000 371 348 $9K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 1,772 1,443 $9K
85652 5,680 5,419 $9K
82785 762 734 $9K
86376 804 790 $8K
93880 82 73 $8K
90651 75 72 $8K
57454 24 24 $8K
92611 132 127 $8K
86707 619 615 $8K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 214 201 $8K
77073 1,362 1,348 $8K
86580 352 336 $7K
94727 231 222 $7K
97760 117 111 $7K
93280 1,095 1,061 $7K
70543 32 30 $7K
92202 446 428 $7K
84155 13,174 10,607 $7K
90792 Psychiatric diagnostic evaluation with medical services 68 66 $7K
73080 719 672 $6K
10060 61 51 $6K
73140 439 402 $6K
0054A 237 231 $6K
67210 31 26 $6K
94726 99 99 $6K
87075 1,289 1,192 $6K
83921 638 622 $6K
86039 874 856 $6K
87350 515 513 $6K
0013A 261 252 $6K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,830 1,049 $6K
82627 312 311 $6K
91065 71 58 $6K
74018 507 465 $6K
82805 138 116 $6K
96127 98 96 $6K
70486 174 171 $6K
84703 849 790 $5K
73564 1,535 1,413 $5K
11981 29 29 $5K
J7120 Ringers lactate infusion, up to 1000 cc 1,941 1,790 $5K
92557 219 218 $5K
86677 500 491 $5K
96377 1,226 885 $5K
88271 70 67 $5K
85014 3,396 3,097 $5K
99495 109 105 $5K
90716 69 68 $5K
86381 420 416 $5K
86300 646 530 $5K
75561 14 14 $5K
82435 6,820 5,270 $5K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,843 1,170 $5K
20605 29 26 $5K
82948 1,936 1,777 $5K
92250 579 546 $5K
85018 4,105 3,812 $5K
87116 726 559 $5K
90480 247 245 $5K
72070 218 215 $5K
84681 433 413 $4K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 54 27 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 448 362 $4K
97116 81 56 $4K
90656 339 333 $4K
87496 135 124 $4K
95885 13 12 $4K
0064A 123 121 $4K
88360 63 61 $4K
82977 4,923 4,714 $4K
82962 2,531 1,832 $4K
96132 54 53 $4K
82960 909 881 $4K
87015 1,042 850 $4K
J0780 Injection, prochlorperazine, up to 10 mg 1,325 1,146 $4K
86355 280 272 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,619 1,928 $4K
0134A 167 164 $4K
77001 281 274 $4K
99222 Initial hospital care, per day, moderate complexity 13 13 $4K
J2997 Injection, alteplase recombinant, 1 mg 29 25 $4K
0071A 88 88 $4K
82172 455 451 $4K
86334 461 439 $4K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 776 725 $4K
0053A 94 93 $4K
86870 136 128 $4K
96409 107 73 $4K
87493 691 668 $4K
93299 197 182 $3K
86777 488 467 $3K
90632 122 122 $3K
89051 1,041 936 $3K
J2785 Injection, regadenoson, 0.1 mg 576 557 $3K
0072A 76 75 $3K
73565 265 259 $3K
87252 143 140 $3K
86644 349 341 $3K
82374 3,998 3,021 $3K
51729 14 12 $3K
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 141 141 $3K
73552 555 528 $3K
36902 12 12 $3K
75574 13 13 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 8,809 7,345 $3K
97113 41 16 $3K
G0009 Administration of pneumococcal vaccine 444 441 $3K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 1,667 1,595 $3K
0296T 54 50 $2K
87177 445 406 $2K
86015 417 412 $2K
J7060 5% dextrose/water (500 ml = 1 unit) 2,065 1,032 $2K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit 103 79 $2K
86357 149 144 $2K
76818 62 58 $2K
82810 448 420 $2K
A4649 Surgical supply; miscellaneous 2,503 2,065 $2K
93271 24 24 $2K
87486 93 87 $2K
87581 93 87 $2K
78306 13 13 $2K
J0640 Injection, leucovorin calcium, per 50 mg 1,368 746 $2K
99441 352 255 $2K
87206 524 397 $2K
86696 112 112 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 1,048 799 $2K
87902 14 14 $2K
92136 110 106 $2K
86147 62 62 $2K
72157 15 15 $2K
J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg 12 12 $2K
86645 237 233 $2K
J2370 Injection, phenylephrine hcl, up to 1 ml 6,061 5,056 $2K
80164 350 321 $2K
J3470 Injection, hyaluronidase, up to 150 units 238 223 $2K
88264 26 24 $2K
84630 207 206 $2K
90707 64 63 $2K
86364 303 297 $2K
86665 75 73 $2K
72110 164 164 $2K
ATP18 280 242 $2K
72170 273 196 $2K
88311 288 271 $2K
86695 124 124 $2K
73523 40 38 $2K
86880 344 319 $1K
86141 162 156 $1K
87210 432 417 $1K
91307 131 115 $1K
G0444 Annual depression screening, 5 to 15 minutes 1,675 1,638 $1K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 27 27 $1K
98967 76 67 $1K
93225 13 13 $1K
93226 13 13 $1K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 31 24 $1K
93356 823 804 $1K
64447 12 12 $1K
97163 13 13 $1K
0052A 28 28 $1K
87529 26 26 $1K
82610 116 113 $1K
C9399 Unclassified drugs or biologicals 117 110 $1K
88275 15 14 $1K
92504 26 26 $1K
84207 46 45 $1K
88309 15 15 $1K
88302 192 189 $991.95
90674 325 311 $914.15
92020 364 357 $912.31
90691 12 12 $912.24
99221 81 26 $901.94
83993 90 89 $882.81
86146 14 14 $875.55
86037 39 39 $832.92
72146 15 15 $814.66
84478 478 456 $780.32
86709 113 108 $761.01
85384 101 73 $747.15
0051A 18 18 $733.92
86705 183 151 $726.60
86664 75 73 $726.43
80178 147 137 $714.04
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 892 787 $698.08
J1010 Injection, methylprednisolone acetate, 1 mg 328 314 $695.05
88300 142 136 $684.51
J9190 Injection, fluorouracil, 500 mg 2,593 982 $664.32
85049 518 376 $663.41
S0028 Injection, famotidine, 20 mg 352 218 $650.20
90714 39 39 $648.98
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 40 34 $640.20
86692 47 47 $639.60
11721 43 43 $638.07
84300 310 279 $635.19
G0103 Prostate cancer screening; prostate specific antigen test (psa) 515 506 $584.30
C7901 Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service 250 145 $529.06
87625 31 29 $513.41
84445 12 12 $510.29
93976 12 12 $495.85
J3471 Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) 13 12 $485.66
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 118 114 $480.80
73060 56 48 $478.18
82010 77 71 $441.44
85705 53 53 $431.40
82088 13 13 $431.28
85613 53 53 $429.17
86431 143 135 $410.65
90633 12 12 $401.88
80047 49 49 $387.53
36416 908 893 $379.26
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 189 179 $378.82
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 465 457 $371.17
J9045 Injection, carboplatin, 50 mg 510 339 $365.36
83519 19 19 $364.86
87269 56 54 $361.44
84481 28 28 $343.62
87272 56 54 $337.92
J9267 Injection, paclitaxel, 1 mg 449 218 $330.36
82330 55 54 $318.36
99386 15 13 $314.14
84436 38 37 $306.46
86711 133 131 $305.41
P9047 Infusion, albumin (human), 25%, 50 ml 35 14 $280.30
84244 13 13 $271.60
C1887 Catheter, guiding (may include infusion/perfusion capability) 197 189 $267.28
74019 12 12 $257.28
82955 32 32 $256.80
73700 15 14 $253.14
80179 31 31 $246.60
87467 19 19 $246.35
82077 126 96 $243.68
83935 88 75 $234.14
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 15 12 $232.34
51702 57 52 $223.17
91312 376 371 $222.36
83789 13 12 $222.27
82103 24 24 $216.17
88142 12 12 $214.44
80158 43 13 $204.82
86336 12 12 $192.84
76514 50 50 $191.70
91305 466 445 $185.37
83026 55 54 $184.08
86335 12 12 $181.23
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 332 290 $177.27
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 14 14 $170.61
36592 42 40 $157.60
93000 312 304 $148.70
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 201 189 $135.12
84402 12 12 $132.00
J0330 Injection, succinylcholine chloride, up to 20 mg 3,132 2,194 $125.42
93246 47 47 $123.44
84590 12 12 $122.88
82525 14 13 $120.45
J0461 Injection, atropine sulfate, 0.01 mg 40 25 $115.16
83930 42 36 $114.57
J8540 Dexamethasone, oral, 0.25 mg 2,260 1,326 $113.63
83525 13 13 $110.88
G0442 Annual alcohol misuse screening, 5 to 15 minutes 126 126 $108.95
84157 45 39 $108.83
C1781 Mesh (implantable) 12 12 $107.47
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 436 385 $106.08
83037 52 51 $103.23
11719 17 13 $102.62
87899 12 12 $102.34
80321 517 487 $88.40
93270 12 12 $76.40
85732 13 13 $74.23
J1596 Injection, glycopyrrolate, 0.1 mg 171 138 $72.23
92567 107 106 $70.97
46600 100 99 $63.12
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 12 12 $62.43
G0010 Administration of hepatitis b vaccine 98 98 $60.30
86308 12 12 $50.27
P3000 Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision 21 21 $45.84
82270 14 13 $42.77
13132 13 12 $42.15
C1729 Catheter, drainage 533 495 $40.12
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 55 55 $39.08
80348 776 553 $35.90
90678 20 20 $26.84
73090 13 13 $20.14
J1171 Injection, hydromorphone, 0.1 mg 271 178 $19.76
J2919 Injection, methylprednisolone sodium succinate, 5 mg 238 188 $19.65
89060 12 12 $14.76
J2765 Injection, metoclopramide hcl, up to 10 mg 465 416 $10.66
C9113 Injection, pantoprazole sodium, per vial 88 51 $9.07
98968 15 15 $7.78
Q0247 Injection, sotrovimab, 500 mg 30 30 $3.77
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg 123 123 $0.02
91313 121 120 $0.02
91306 105 104 $0.01
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 1,014 956 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 89 87 $0.00
80346 87 53 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 1,101 1,035 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 1,558 1,119 $0.00
90649 211 211 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 150 147 $0.00
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml 250 239 $0.00
17003 161 156 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 109 106 $0.00
90460 Immunization administration through 18 years of age via any route, first or only component 14 14 $0.00
93321 28 28 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 92 39 $0.00
51701 12 12 $0.00
80143 31 31 $0.00
69209 17 17 $0.00
80373 31 28 $0.00
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 107 105 $0.00
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 44 40 $0.00
95970 29 27 $0.00
72050 14 14 $0.00
96138 14 14 $0.00
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 43 29 $0.00
80361 87 56 $0.00
96133 29 28 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 12 12 $0.00
G0204 Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral 15 15 $0.00
91301 2,423 1,916 $0.00
Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 195 141 $0.00
J1940 Injection, furosemide, up to 20 mg 449 296 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 124 124 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 50 50 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 13 13 $0.00
Q0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg 93 90 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 400 391 $0.00
C1726 Catheter, balloon dilatation, non-vascular 60 55 $0.00
V2632 Posterior chamber intraocular lens 14 13 $0.00
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg 56 54 $0.00
G0206 Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral 15 13 $0.00
A4217 Sterile water/saline, 500 ml 104 104 $0.00
51797 25 25 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 54 41 $0.00
J3480 Injection, potassium chloride, per 2 meq 12 12 $0.00
17312 13 13 $0.00
96139 14 14 $0.00